BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9121293)

  • 1. Hydroxyethylstarch and renal function in kidney transplant recipients.
    Coronel B; Mercatello A; Martin X; Lefrancois N
    Lancet; 1997 Mar; 349(9055):884; author reply 884. PubMed ID: 9121293
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydroxyethylstarch and renal function in kidney transplant recipients.
    Holzheimer R
    Lancet; 1997 Mar; 349(9055):883-4; author reply 884. PubMed ID: 9121292
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.
    Cittanova ML; Leblanc I; Legendre C; Mouquet C; Riou B; Coriat P
    Lancet; 1996 Dec; 348(9042):1620-2. PubMed ID: 8961992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants.
    Bernard C; Alain M; Simone C; Xavier M; Jean-François M
    Lancet; 1996 Dec; 348(9041):1595. PubMed ID: 8950915
    [No Abstract]   [Full Text] [Related]  

  • 5. Osmotic nephrosis in a renal transplant recipient.
    Ebcioglu Z; Cohen DJ; Crew RJ; Hardy MA; Ratner LE; D'Agati VD; Markowitz GS
    Kidney Int; 2006 Nov; 70(10):1873-6. PubMed ID: 16883320
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.
    Schortgen F; Lacherade JC; Bruneel F; Cattaneo I; Hemery F; Lemaire F; Brochard L
    Lancet; 2001 Mar; 357(9260):911-6. PubMed ID: 11289347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Gosling P; Rittoo D; Manji M; Mahmood A; Vohra R
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526921
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the novel hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation.
    Blasco V; Leone M; Antonini F; Geissler A; Albanèse J; Martin C
    Br J Anaesth; 2008 Apr; 100(4):504-8. PubMed ID: 18256055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Godet G
    Lancet; 2001 Aug; 358(9281):581; author reply 582. PubMed ID: 11526922
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxyethylstarch as a risk factor for acute renal failure in severe sepsis.
    Boldt J
    Lancet; 2001 Aug; 358(9281):581-3. PubMed ID: 11526920
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxyethyl starch.
    Treib J; Haass A
    J Neurosurg; 1997 Mar; 86(3):574-5. PubMed ID: 9046322
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up of transplanted kidneys according to plasma volume expander of kidney donors.
    Cittanova ML; Mavré J; Riou B; Coriat P
    Intensive Care Med; 2001 Nov; 27(11):1830. PubMed ID: 11810131
    [No Abstract]   [Full Text] [Related]  

  • 13. Nephrotoxicity of hydroxyethyl starch solution.
    Brunkhorst FM; Oppert M
    Br J Anaesth; 2008 Jun; 100(6):856; author reply 856-7. PubMed ID: 18483113
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient.
    De Labarthe A; Jacobs F; Blot F; Glotz D
    Am J Med; 2001 Oct; 111(5):417-8. PubMed ID: 11599525
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxyethyl starch: safe or not?
    Warren BB; Durieux ME
    Anesth Analg; 1997 Jan; 84(1):206-12. PubMed ID: 8989026
    [No Abstract]   [Full Text] [Related]  

  • 16. Is the literature inconclusive about the harm of HES? We are not sure.
    Schetz M; Shaw AD; Vincent JL
    Intensive Care Med; 2017 Oct; 43(10):1526-1528. PubMed ID: 27007103
    [No Abstract]   [Full Text] [Related]  

  • 17. The nephrotoxicity of 6% Hydroxyethyl Starch 130/0.4 in surgery.
    Kancir AS
    Acta Anaesthesiol Scand; 2016 Apr; 60(4):548-9. PubMed ID: 26941118
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term outcome in kidney recipients from donors treated with hydroxyethylstarch 130/0.4 and hydroxyethylstarch 200/0.6.
    Blasco V; Colavolpe JC; Antonini F; Zieleskiewicz L; Nafati C; Albanèse J; Leone M
    Br J Anaesth; 2015 Nov; 115(5):798. PubMed ID: 26475812
    [No Abstract]   [Full Text] [Related]  

  • 19. Renal impairment in cardiac surgery patients receiving hydroxyethyl starch.
    Wiedermann CJ
    Intensive Care Med; 2004 Mar; 30(3):519-20; author reply 521. PubMed ID: 14727021
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment?
    Mills GH
    Br J Anaesth; 2007 Feb; 98(2):157-9. PubMed ID: 17251208
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.